Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2709)
All Articles published online
|
Jun 15, 2002 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qin LX, Tang ZY, Ma ZC, Wu ZQ, Zhou XD, Ye QH, Ji Y, Huang LW, Jia HL, Sun HC, Wang L. p53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection. World J Gastroenterol 2002; 8(3): 459-463 [PMID: 12046070 DOI: 10.3748/wjg.v8.i3.459] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i3/459.htm |
| Number | Citing Articles |
| 1 |
Jiangbo Liu, Qingyong Ma, Min Zhang, Xinshuai Wang, Dong Zhang, Wei Li, Fengfei Wang, Erxi Wu. Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: Evidence from a systematic review and meta-analysis. European Journal of Cancer 2012; 48(15): 2328 doi: 10.1016/j.ejca.2012.03.001
|
| 2 |
Mehdi Pouraminaei, Mohammad Reza Mirzaiey, Alireza Khoshdel, Mohammad Reza Hajizadeh, Mehdi Mahmoodi, Mohammad Ali Fahmidehkar. The effect of Cressa Cretica hydroalcoholic extract on apoptosis and the expression of Bcl2, Bax and P53 genes in hepatoma cell line HepG2. Gene Reports 2020; 20: 100692 doi: 10.1016/j.genrep.2020.100692
|
| 3 |
Sanjay Kakar. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 849 doi: 10.1007/978-1-4419-7107-4_57
|
| 4 |
Laetitia Fartoux, Thomas Decaens. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2011; 35: S21 doi: 10.1016/S2210-7401(11)70004-3
|
| 5 |
Ya-nan Ji, Qin Wang, Jun Xue. TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis. Tumor Biology 2014; 35(2): 1653 doi: 10.1007/s13277-013-1228-7
|
| 6 |
Wesam A. Nasif, Mohammed H. Mukhtar, Hoda M. El-Emshaty, Talaat A. AL-Bukhari. Evaluation of circulating TP53 antigen in the sera of gastric cancer patients: As a tumor marker. Biomarkers and Genomic Medicine 2013; 5(4): 175 doi: 10.1016/j.bgm.2013.10.001
|
| 7 |
Xing-Hua Huang, Lu-Hong Sun, Dong-Dong Lu, Yan Sun, Li-Jie Ma, Xi-Ran Zhang, Jian Huang, Long Yu. Codon 249 mutation in exon 7 of <italic>p53</italic> gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China. World Journal of Gastroenterology 2003; 9(4): 692-695 doi: 10.3748/wjg.v9.i4.692
|
| 8 |
Sadiyah Samreen, Elhan Khan, Iffat Zareen Ahmad. Molecular docking and molecular dynamics simulation analysis of bioactive compounds ofCichorium intybusL. seed against hepatocellular carcinoma. Journal of Biomolecular Structure and Dynamics 2023; : 1 doi: 10.1080/07391102.2023.2250465
|
| 9 |
Mulazim Hussain Bukhari, Shahida Niazi, Muhammad Anwar, Naseer Ahmed Chaudhry, Samina Naeem. Prognostic Significance of New Immunohistochemistry Scoring of p53 Protein Expression in Cutaneous Squamous Cell Carcinoma of Mice. Annals of the New York Academy of Sciences 2008; 1138(1): 1 doi: 10.1196/annals.1414.001
|
| 10 |
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. European Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
|
| 11 |
Neeta K. Venepalli, Laura Goff. Targeting the HGF-cMET Axis in Hepatocellular Carcinoma. International Journal of Hepatology 2013; 2013: 1 doi: 10.1155/2013/341636
|
| 12 |
Li-Juan Shen, Hua-Xian Zhang, Zong-Ji Zhang, Jin-Yun Li, Ming-Qin Chen, Wei-Bo Yang, Run Huang. Detection of HBV, PCNA and GST-π in hepatocellular carcinoma and chronic liver diseases. World Journal of Gastroenterology 2003; 9(3): 459-462 doi: 10.3748/wjg.v9.i3.459
|
| 13 |
Xin-Juan Kong, Yu-Hu Song, Ju-Sheng Lin, Huan-Jun Huang, Nan-Xia Wang, Nan-Zhi Liu, Bin Li, You-Xin Jin. Maxizyme-mediated specific inhibition on mutant-type p53 <italic>in vitro</italic>. World Journal of Gastroenterology 2003; 9(7): 1571-1575 doi: 10.3748/wjg.v9.i7.1571
|
| 14 |
Perumal Vivekanandan, Om V Singh. High-dimensional biology to comprehend hepatocellular carcinoma. Expert Review of Proteomics 2008; 5(1): 45 doi: 10.1586/14789450.5.1.45
|
| 15 |
Toar J.M. Lalisang, Yefta Moenadjat, Nurjati C. Siregar, Marini Stephanie. Overexpression of p53 in extra large (more than 10 cm) hepatocellular carcinoma. Medical Journal of Indonesia 2018; 27(2) doi: 10.13181/mji.v27i2.1980
|
| 16 |
Reza Ghasemi, Seyed H. Ghaffari, Majid Momeny, Saeed Pirouzpanah, Mehdi Yousefi, Mohsen Malehmir, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Multitargeting and Antimetastatic Potentials of Silibinin in Human HepG-2 and PLC/PRF/5 Hepatoma Cells. Nutrition and Cancer 2013; 65(4): 590 doi: 10.1080/01635581.2013.770043
|
| 17 |
Chaar Ines, Ounissi Donia, Boughriba Rahma, Azza Ben Ammar, Amara Sameh, Taher Khalfallah, Ben hmida Abdelmajid, Mzabi Sabeh, Bouraoui Saadia. Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort. Tumor Biology 2014; 35(7): 7163 doi: 10.1007/s13277-014-1874-4
|
| 18 |
Li-Wu Lin, Xue-Ying Lin, Yi-Mi He, Shang-Da Gao, Xiao-Dong Lin. Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical application. World Journal of Gastroenterology 2003; 9(5): 941-945 doi: 10.3748/wjg.v9.i5.941
|
| 19 |
Regina Cheuk-Lam Lo, Irene Oi-Lin Ng. Hepatocellular tumors: Immunohistochemical analyses for classification and prognostication. Chinese Journal of Cancer Research 2011; 23(4): 245 doi: 10.1007/s11670-011-0245-6
|
| 20 |
Lun-Xiu Qin, Zhao-You Tang. The prognostic molecular markers in hepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(3): 385-392 doi: 10.3748/wjg.v8.i3.385
|
| 21 |
Zhao-Chong Zeng, Guo-Liang Jiang, Guo-Min Wang, Zhao-You Tang, Walter J. Curran, George Iliakis. DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line. World Journal of Gastroenterology 2002; 8(5): 797-803 doi: 10.3748/wjg.v8.i5.797
|
| 22 |
Jian-Zhen Lin, Jun-Yu Long, An-Qiang Wang, Ying Zheng, Hai-Tao Zhao. Precision medicine: In need of guidance and surveillance. World Journal of Gastroenterology 2017; 23(28): 5045-5050 doi: 10.3748/wjg.v23.i28.5045
|
| 23 |
Rageshree Ramachandran, Sanjay Kakar. Fibrolamellar hepatocellular carcinoma. Diagnostic Histopathology 2010; 16(8): 388 doi: 10.1016/j.mpdhp.2010.06.005
|
| 24 |
Laura Gramantieri, Davide Trerè, Pasquale Chieco, Michela Lacchini, Catia Giovannini, Fabio Piscaglia, Antonino Cavallari, Luigi Bolondi. In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair. Journal of Hepatology 2003; 39(6): 997 doi: 10.1016/S0168-8278(03)00458-6
|
| 25 |
Michael Torbenson, Rajesh Kannangai, Susan Abraham, Fikret Sahin, Michael Choti, Jianzhou Wang. Concurrent Evaluation of p53, β-Catenin, and α-Fetoprotein Expression in Human Hepatocellular Carcinoma. American Journal of Clinical Pathology 2004; 122(3): 377 doi: 10.1309/YH0H3FKYM4RMU1JF
|
| 26 |
Richard A. Burkhart, Sean M. Ronnekleiv-Kelly, Timothy M. Pawlik. Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response. Surgical Oncology 2017; 26(2): 138 doi: 10.1016/j.suronc.2017.01.009
|
| 27 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
| 28 |
Kenji Yorita, Akinobu Ohno, Hiroaki Kataoka. Emerging histopathological prognostic biomarkers in hepatocellular carcinomas. Personalized Medicine Universe 2014; 3: 15 doi: 10.1016/j.pmu.2014.03.006
|
| 29 |
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
|
| 30 |
Mulazim H. Bukhari, Shahida Niazi, Muhammad Eyyaz Khaleel, M. Anwar Sharif, Rubina Ghani, Muhammad T. Mehmood, Muhammad Tahseen, Naseer A. Chaudhry, Mumtaz Hasan. Elevated frequency of p53 genetic mutations and AgNOR values in squamous cell carcinoma. Journal of Cutaneous Pathology 2009; 36(2): 220 doi: 10.1111/j.1600-0560.2008.01006.x
|
| 31 |
Laura Gramantieri, Pasquale Chieco, Catia Giovannini, Michela Lacchini, Davide Treré, Gian Luca Grazi, Annamaria Venturi, Luigi Bolondi. GADD45-α expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation. Human Pathology 2005; 36(11): 1154 doi: 10.1016/j.humpath.2005.07.017
|
| 32 |
Zhao-Shan Niu, Bo-Kian Li, Mei Wang. Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues. World Journal of Gastroenterology 2002; 8(5): 822-826 doi: 10.3748/wjg.v8.i5.822
|